A Multicenter, Open-label, Long-term, Safety, Tolerability, and Efficacy Study of XEN1101 in Adults Diagnosed With Epilepsy (X-TOLE4)

Grants and Contracts Details

StatusActive
Effective start/end date10/10/2310/10/25

Funding

  • Xenon Pharmaceuticals Incorporated: $26,686.00